Smith Sandford D's Form 4 filing
Cytokinetics Inc (CYTK) · filed Dec 28, 2021
- Accession no.
- 0001061983-21-000268
- Filed
- Dec 28, 2021
- Trade date
- Dec 27, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.30M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Sandford DCIK 0001243004 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2021 | Common Stock | MOption exerciseAcquired | +4,166 | $24.32 | +$101,317.12 | 10,931 | Direct | |
| Dec 27, 2021 | Common Stock | SSaleDisposed | −4,166 | $45.79 | −$190,761.14 | 6,765 | Direct | |
| Dec 27, 2021 | Common Stock | MOption exerciseAcquired | +20,000 | $21.61 | +$432,200 | 26,765 | Direct | |
| Dec 27, 2021 | Common Stock | SSaleDisposed | −20,000 | $45.79 | −$915,800 | 6,765 | Direct | |
| Dec 27, 2021 | Common Stock | MOption exerciseAcquired | +4,124 | $15.43 | +$63,633.32 | 10,889 | Direct | |
| Dec 27, 2021 | Common Stock | SSaleDisposed | −4,124 | $45.79 | −$188,837.96 | 6,765 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2021 | Common Stock | MOption exerciseDisposed | −4,124 | $0.00 | $0 | 0 | Direct | |
| Dec 27, 2021 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct | |
| Dec 27, 2021 | Common Stock | MOption exerciseDisposed | −4,166 | $0.00 | $0 | 5,834 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.